Modern insulin treatment for type 2 diabetes

Emilie Grønlund; Lærke Lund; Tina Vilsbøll; Sofie Hædersdal

doi:10.61409/V03240172

Modern insulin treatment for type 2 diabetes

Translated title of the contribution: Not Available

Emilie Grønlund, Lærke Lund, Tina Vilsbøll, Sofie Hædersdal

Steno Diabetes Center Copenhagen

Abstract

This review summarises the current and possible future insulin treatment of type 2 diabetes. The type 2 diabetes treatment guidelines prioritise a person-centred approach with various options before insulin addressing cardiorenal protection. Long-acting daily insulin injections are warranted in severe hyperglycaemia or when glycaemic targets are not met. Insulin, when possible, should be combined with other agents to lower insulin dosage, weight gain and hypoglycaemia. Once-weekly insulin offers a promising treatment, reducing injection burden, enhancing treatment satisfaction, and lowering the risk of severe hypoglycaemia, potentially improving type 2 diabetes management.

Translated title of the contribution	Not Available
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	186
Issue number	28
ISSN	0041-5782
DOIs	https://doi.org/10.61409/V03240172
Publication status	Published - 8 Jul 2024

Access to Document

10.61409/V03240172

Cite this

@article{67bdc37e19a34fe188e5ebf14c270ff6,

title = "Modern insulin treatment for type 2 diabetes",

abstract = "This review summarises the current and possible future insulin treatment of type 2 diabetes. The type 2 diabetes treatment guidelines prioritise a person-centred approach with various options before insulin addressing cardiorenal protection. Long-acting daily insulin injections are warranted in severe hyperglycaemia or when glycaemic targets are not met. Insulin, when possible, should be combined with other agents to lower insulin dosage, weight gain and hypoglycaemia. Once-weekly insulin offers a promising treatment, reducing injection burden, enhancing treatment satisfaction, and lowering the risk of severe hypoglycaemia, potentially improving type 2 diabetes management.",

keywords = "Humans, Diabetes Mellitus, Type 2/drug therapy, Hypoglycemic Agents/therapeutic use, Insulin/administration & dosage, Hypoglycemia/chemically induced, Drug Administration Schedule",

author = "Emilie Gr{\o}nlund and L{\ae}rke Lund and Tina Vilsb{\o}ll and Sofie H{\ae}dersdal",

note = "Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2024",

month = jul,

day = "8",

doi = "10.61409/V03240172",

language = "Dansk",

volume = "186",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "28",

}

TY - JOUR

T1 - Modern insulin treatment for type 2 diabetes

AU - Grønlund, Emilie

AU - Lund, Lærke

AU - Vilsbøll, Tina

AU - Hædersdal, Sofie

N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2024/7/8

Y1 - 2024/7/8

N2 - This review summarises the current and possible future insulin treatment of type 2 diabetes. The type 2 diabetes treatment guidelines prioritise a person-centred approach with various options before insulin addressing cardiorenal protection. Long-acting daily insulin injections are warranted in severe hyperglycaemia or when glycaemic targets are not met. Insulin, when possible, should be combined with other agents to lower insulin dosage, weight gain and hypoglycaemia. Once-weekly insulin offers a promising treatment, reducing injection burden, enhancing treatment satisfaction, and lowering the risk of severe hypoglycaemia, potentially improving type 2 diabetes management.

AB - This review summarises the current and possible future insulin treatment of type 2 diabetes. The type 2 diabetes treatment guidelines prioritise a person-centred approach with various options before insulin addressing cardiorenal protection. Long-acting daily insulin injections are warranted in severe hyperglycaemia or when glycaemic targets are not met. Insulin, when possible, should be combined with other agents to lower insulin dosage, weight gain and hypoglycaemia. Once-weekly insulin offers a promising treatment, reducing injection burden, enhancing treatment satisfaction, and lowering the risk of severe hypoglycaemia, potentially improving type 2 diabetes management.

KW - Humans

KW - Diabetes Mellitus, Type 2/drug therapy

KW - Hypoglycemic Agents/therapeutic use

KW - Insulin/administration & dosage

KW - Hypoglycemia/chemically induced

KW - Drug Administration Schedule

UR - http://www.scopus.com/inward/record.url?scp=85200939916&partnerID=8YFLogxK

U2 - 10.61409/V03240172

DO - 10.61409/V03240172

M3 - Tidsskriftartikel

C2 - 39115232

SN - 0041-5782

VL - 186

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 28

ER -

Modern insulin treatment for type 2 diabetes

Abstract

Access to Document

Other files and links

Fingerprint

Cite this